How Big Is Pfizer's Vaccine Opportunity in India?

·2-min read

Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) are hoping to have an opportunity to win authorization for their COVID-19 vaccine in India. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss just how big Pfizer's opportunity in India could be. Keith Speights: Pfizer ticker, there's P-F-E. Pfizer announced earlier this week that it's talking with the government of India about a potential accelerated pathway to authorization for its COVID-19 vaccine.